<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Cancer Urology</journal-id><journal-title-group><journal-title xml:lang="en">Cancer Urology</journal-title><trans-title-group xml:lang="ru"><trans-title>Онкоурология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1726-9776</issn><issn publication-format="electronic">1996-1812</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">965</article-id><article-id pub-id-type="doi">10.17650/1726-9776-2019-15-3-120-124</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>UROLOGICAL COMPLICATIONS IN CANCER PATIENTS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>УРОЛОГИЧЕСКИЕ ОСЛОЖНЕНИЯ У ОНКОЛОГИЧЕСКИХ БОЛЬНЫХ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Approaches for breast cancer treatment in kidney transplant recipient</article-title><trans-title-group xml:lang="ru"><trans-title>Тактика лечения рака молочной железы у пациентки с почечным трансплантатом</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7141-2502</contrib-id><name-alternatives><name xml:lang="en"><surname>Zikiryahodzhaev</surname><given-names>A. D.</given-names></name><name xml:lang="ru"><surname>Зикиряходжаев</surname><given-names>А. Д.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><italic>3 2nd Botkinskiy Proezd, Moscow 125284</italic></p></bio><bio xml:lang="ru"><p><bold>Азиз Закиряходжаев, </bold>руководитель отделения онкологии и реконструктивно-пластической хирургии молочной железы и кожи</p><p><italic>125284 Москва, 2-й Боткинский проезд, 3 </italic></p></bio><email>azizz@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0307-8252</contrib-id><name-alternatives><name xml:lang="en"><surname>Rasskazova</surname><given-names>E. A.</given-names></name><name xml:lang="ru"><surname>Рассказова</surname><given-names>Е. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><italic>3 2nd Botkinskiy Proezd, Moscow 125284</italic></p></bio><bio xml:lang="ru"><p><bold>Елена Александровна Рассказова, </bold>научный сотрудник отделения онкологии и реконструктивно-пластической хирургии молочной железы и кожи</p><p><italic>125284 Москва, 2-й Боткинский проезд, 3 </italic></p></bio><email>rasskaz2@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4954-3666</contrib-id><name-alternatives><name xml:lang="en"><surname>Idigova</surname><given-names>R. M.</given-names></name><name xml:lang="ru"><surname>Идигова</surname><given-names>Р. М.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><italic>3 2nd Botkinskiy Proezd, Moscow 125284</italic></p></bio><bio xml:lang="ru"><p><bold>Раиса М. Идигова</bold>, клинический ординатор</p><p><italic>125284 Москва, 2-й Боткинский проезд, 3 </italic></p></bio><email>idigova91@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8784-8415</contrib-id><name-alternatives><name xml:lang="en"><surname>Kaprin</surname><given-names>A. D.</given-names></name><name xml:lang="ru"><surname>Каприн</surname><given-names>А. Д.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><italic>3 2nd Botkinskiy Proezd, Moscow 125284</italic></p></bio><bio xml:lang="ru"><p><bold>Андрей Д. Каприн</bold>, генеральный директор </p><p><italic>125284 Москва, 2-й Боткинский проезд, 3 </italic></p></bio><email>kaprin@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4171-6211</contrib-id><name-alternatives><name xml:lang="en"><surname>Nyushko</surname><given-names>K. M.</given-names></name><name xml:lang="ru"><surname>Нюшко</surname><given-names>К. М.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><italic>3 2nd Botkinskiy Proezd, Moscow 125284</italic></p></bio><bio xml:lang="ru"><p><bold>Кирилл М. Нюшин</bold>, ведущий научный сотрудник отделения онкоурологии </p><p><italic>125284 Москва, 2-й Боткинский проезд, 3 </italic></p></bio><email>kirandja@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Р. Hertzen Moscow Oncology Research Institute – Branch of the National Medical Research Radiological Center, Ministry of Health of Russia</institution></aff><aff><institution xml:lang="ru">Московский научно-исследовательский онкологический институт им. П.А. Герцена – филиал ФГБУ «Национальный медицинский исследовательский центр радиологии» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2019-09-30" publication-format="electronic"><day>30</day><month>09</month><year>2019</year></pub-date><volume>15</volume><issue>3</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>120</fpage><lpage>124</lpage><history><date date-type="received" iso-8601-date="2019-07-29"><day>29</day><month>07</month><year>2019</year></date><date date-type="accepted" iso-8601-date="2019-08-23"><day>23</day><month>08</month><year>2019</year></date></history><permissions><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://oncourology.abvpress.ru/oncur/article/view/965">https://oncourology.abvpress.ru/oncur/article/view/965</self-uri><abstract xml:lang="en"><p><bold>Objective </bold>– the choice of tactics for the treatment of breast cancer in a kidney transplant recipient. The article presents a clinical case of a 51-year-old patient with a clinical diagnosis: left breast cancer IIA stage рТ2N0М0G3; triple-negative type. About chronic renal failure 10 years ago the patient was kidney transplantation was performed. The development of transplantation has expanded the use of immunosuppressive therapy in clinical practice. As a result, the risk the development of secondary tumors, including breast cancer, increases.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Цель исследования – </bold>выбор тактики лечения рака молочной железы у реципиента почечного трансплантата. В статье представлено клиническое наблюдение пациентки 51 года с клиническим диагнозом: рак левой молочной железы IIA стадии рТ2N0М0G3; тройной негативный тип. По поводу хронической почечной недостаточности 10 лет назад пациентке была выполнена трансплантация почки. Развитие трансплантологии расширило применение в клинической практике иммуносупрессивной терапии. В результате риск развития вторичных опухолей, в том числе рака молочной железы, возрастает.</p></trans-abstract><kwd-group xml:lang="en"><kwd>breast cancer</kwd><kwd>kidney transplantation</kwd><kwd>immunosuppressive therapy</kwd><kwd>surgical treatment</kwd><kwd>chronic renal failure</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>рак молочной железы</kwd><kwd>трансплантация почки</kwd><kwd>иммуносупрессивная терапия</kwd><kwd>хирургическое лечение</kwd><kwd>хроническая почечная недостаточность</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Heo J., Noh O.К., Oh Y.T. еt al. Cancer risk after renal transplantation in South Korea: a nationwide populationbased study. BMC Nephrology 2018;19:311–7. DOI: 10.1186/s12882-018-1110-3.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Villeneuvea P.J., Schaubelb D.E., Fentonc S.S. еt al. Cancer Incidence among canadian kidney transplant recipients. Am J Transplant 2007;7:941–8. DOI: 10.1111/j.1600-6143.2007.01736.x.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Roussel J.C., Baron O., Périgaud Ch. еt al. Outcome of heart transplants 15 to 20 years ago: graft survival, posttransplant morbidity, and risk factors for mortality. J Heart Lung Transplant 2008;27(5):486–93. DOI: 10.1016/j.healun.2008.01.019.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Self M., Dunn E., Cox J. еt al. Managing breast cancer in the renal transplant patient: a unique dilemma. Breast Cancer Renal Transplant 2006;72(2):150–3.</mixed-citation></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">Perlin D.V., Darenkov S.P. Vestnik transplantologii i iskusstvennykh organov 2010;12(2):61–6. D.V. Perlin, S.P. Darenkov. Treatment of an invasive Urine Bladder cancer, after renal transplantation. Vestnik transplantologii i iskusstvennykh organov = Russian Journal of Transplantology and Artificial Organs 2010;12(2):61–6. (In Russ). DOI: 10.15825/19995-1191-2010-261-66.</mixed-citation><mixed-citation xml:lang="ru">Перлин Д.В., Даренков С.П. Лечение инвазивного рака мочевого пузыря после трансплантации почки. Вестник трансплантологии и искусственных органов 2010;12(2):61–6. DOI: 10.15825/19995-1191-2010-261-66.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><mixed-citation>Jeong I.Ji., Lee S.G., Kim Y.H. еt al. Characteristics and prognosis of breast cancer after liver or kidney transplantation. Breast Cancer Renal Transplant 2018;167(1):101–6. DOI: 10.1007/s10549-017-4504-1.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Kato T., Kakuta Y., Yamanaka K. еt al. Early diagnosis and treatment of breast cancer in Japanese kidney transplant recipients: a single center experience. Springer Plus 2015;4:196–200. DOI: 10.1186/s40064-015-0946-2.</mixed-citation></ref></ref-list></back></article>
